Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%

PURPOSE: To examine the pooled per-protocol ocular end points from two conjunctival allergen challenge (CAC) clinical trials of the dual-action antihistamine bepotastine besilate ophthalmic solution (BBOS) 1.5%. METHODS: Two Phase III, placebo-controlled, double-masked, randomized clinical trials we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergmann, Mark T, Williams, Jon I, Gomes, Paul J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140238/
https://www.ncbi.nlm.nih.gov/pubmed/25152611
http://dx.doi.org/10.2147/OPTH.S66637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140238/
https://www.ncbi.nlm.nih.gov/pubmed/25152611
http://dx.doi.org/10.2147/OPTH.S66637

Ejemplares similares